• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往存在的肝性脑病:真的是选择性经颈静脉肝内门体分流术的禁忌证吗?

Pre-existing Hepatic Encephalopathy: Really a Contraindication to Elective TIPS?

作者信息

Torkian Pooya, Wallace Stephanie, Lim Nicholas, Flanagan Siobhan, Golzarian Jafar, Young Shamar J

机构信息

Vascular and Interventional Radiology, Department of Radiology, University of Minnesota, B-228 Mayo Memorial Building, MMC 292420 Delaware Street S.E., Minneapolis, MN, 55455, USA.

Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, USA.

出版信息

Cardiovasc Intervent Radiol. 2024 Jan;47(1):69-77. doi: 10.1007/s00270-023-03566-z. Epub 2023 Oct 5.

DOI:10.1007/s00270-023-03566-z
PMID:37798432
Abstract

PURPOSE

To evaluate the impact of pre-transjugular intrahepatic portosystemic shunt (TIPS) hepatic encephalopathy (HE) on developing post-TIPS HE.

MATERIALS AND METHODS

In this retrospective, single center observational study, all patients who underwent successful TIPS placement between January 2005 and May 2020 with data pertaining to HE in their chart were included. Patient demographics and procedural details were recorded. Clinical outcomes post-TIPS, were collected and compared across patients with and without pre-TIPS HE.

RESULTS

Of 326 included patients, 159 (159/326, 48.8%) had a history of pre-TIPS HE. In total those without a history of HE were more likely to develop HE during follow up (136 (136/167, 81.4%) vs 107 (107/159, 67.3%), p = 0.001). When evaluating for predictors of developing HE within 3 months of TIPS placement, no significant variables were found on logistic regression, including prior history of HE (HR 1.16 (95% CI 0.73-1.84), p = 0.529). Univariate and multivariate regression analysis, however, showed that a history of HE was predictive of developing HE at any point in the follow-up period (p = 0.002 and p = 0.008, respectively). However, on Kaplan-Meier analysis no significant difference in the development of HE (p = 0.574) or hospital admission for HE (p = 0.554) post-TIPS was seen between patients with and without pre-TIPS HE. Additionally, there was no difference in 3-month survival (p = 0.412) or overall survival post-TIPS survival (p = 0.798).

CONCLUSION

Pre-TIPS HE did not predict the development of HE within 3 months of TIPS. Outcomes such as hospital admission and survivability were not different between patients with and without prior HE.

摘要

目的

评估经颈静脉肝内门体分流术(TIPS)前肝性脑病(HE)对TIPS术后发生HE的影响。

材料与方法

在这项回顾性单中心观察性研究中,纳入了2005年1月至2020年5月期间成功进行TIPS置入且病历中有HE相关数据的所有患者。记录患者的人口统计学资料和手术细节。收集TIPS术后的临床结局,并在有和没有TIPS前HE的患者之间进行比较。

结果

在纳入的326例患者中,159例(159/326,48.8%)有TIPS前HE病史。总体而言,无HE病史的患者在随访期间更有可能发生HE(136例(136/167,81.4%)对107例(107/159,67.3%),p = 0.001)。在评估TIPS置入后3个月内发生HE的预测因素时,逻辑回归未发现显著变量,包括HE既往史(HR 1.16(95%CI 0.73 - 1.84),p = 0.529)。然而,单因素和多因素回归分析表明,HE病史可预测随访期间任何时间发生HE(分别为p = 0.002和p = 0.008)。然而,根据Kaplan-Meier分析,有和没有TIPS前HE的患者在TIPS术后发生HE(p = 0.574)或因HE住院(p = 0.554)方面没有显著差异。此外,3个月生存率(p = 0.412)或TIPS术后总生存率(p = 0.798)也没有差异。

结论

TIPS前HE不能预测TIPS术后3个月内HE的发生。有和没有既往HE的患者在住院和生存能力等结局方面没有差异。

相似文献

1
Pre-existing Hepatic Encephalopathy: Really a Contraindication to Elective TIPS?既往存在的肝性脑病:真的是选择性经颈静脉肝内门体分流术的禁忌证吗?
Cardiovasc Intervent Radiol. 2024 Jan;47(1):69-77. doi: 10.1007/s00270-023-03566-z. Epub 2023 Oct 5.
2
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.经颈静脉肝内门体分流术时经皮穿刺左支门静脉以减少肝性脑病。
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088.
3
History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites.肝性脑病病史不是难治性腹水行经颈静脉肝内门体分流术的禁忌证。
Clin Transl Gastroenterol. 2021 Aug 1;12(8):e00378. doi: 10.14309/ctg.0000000000000378.
4
Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.经颈静脉肝内门体分流术(TIPS)术前肝脏血流动力学与术后肝性脑病发生率的关系。
Hepatobiliary Pancreat Dis Int. 2006 May;5(2):232-6.
5
Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.肝细胞癌合并门静脉高压患者经颈静脉肝内门体分流术后肝性脑病的危险因素
J Gastrointestin Liver Dis. 2015 Sep;24(3):301-7. doi: 10.15403/jgld.2014.1121.243.yao.
6
Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.经颈静脉肝内门体分流术治疗后病毒性肝炎相关肝硬化患者的长期临床结局。
Virol J. 2018 Oct 1;15(1):151. doi: 10.1186/s12985-018-1067-7.
7
Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.门静脉分流支和支架位置可预测经颈静脉肝内门体分流术后的生存情况。
World J Gastroenterol. 2014 Jan 21;20(3):774-85. doi: 10.3748/wjg.v20.i3.774.
8
Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients.糖尿病会增加肝硬化患者经颈静脉肝内门体分流术后肝性脑病的风险。
Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1264-1269. doi: 10.1097/MEG.0000000000001452.
9
Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后肝性脑病预测的吲哚菁绿-R15、Child-Pugh 评分和终末期肝病模型评分的对比研究。
World J Gastroenterol. 2021 Feb 7;27(5):416-427. doi: 10.3748/wjg.v27.i5.416.
10
Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.择期经颈静脉肝内门体分流术后难治性肝性脑病:危险因素及翻修后的结局
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1765-1772. doi: 10.1007/s00270-018-1992-2. Epub 2018 Jun 5.

引用本文的文献

1
Prognostic Performance of Model for End-Stage Liver Disease (MELD) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation.终末期肝病模型(MELD)3.0在经颈静脉肝内门体分流术(TIPS)创建中的预后性能。
Cardiovasc Intervent Radiol. 2025 Jul 14. doi: 10.1007/s00270-025-04116-5.
2
Invited Commentary: Pre-existing Hepatic Encephalopathy: Really a Contraindication to Elective TIPS? by Torkian etal.特邀评论:既往存在肝性脑病:真的是选择性经颈静脉肝内门体分流术的禁忌证吗?作者:托尔基安等人
Cardiovasc Intervent Radiol. 2024 Jan;47(1):78-79. doi: 10.1007/s00270-023-03627-3. Epub 2023 Dec 12.

本文引用的文献

1
History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites.肝性脑病病史不是难治性腹水行经颈静脉肝内门体分流术的禁忌证。
Clin Transl Gastroenterol. 2021 Aug 1;12(8):e00378. doi: 10.14309/ctg.0000000000000378.
2
Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study.经颈静脉肝内门体分流术治疗后显性肝性脑病的预测:一项队列研究。
Hepatol Int. 2021 Jun;15(3):730-740. doi: 10.1007/s12072-021-10188-5. Epub 2021 May 11.
3
Transjugular intrahepatic portosystemic shunt reduces hospital care burden in patients with decompensated cirrhosis.
经颈静脉肝内门体分流术可减轻失代偿期肝硬化患者的住院负担。
Intern Emerg Med. 2021 Sep;16(6):1519-1527. doi: 10.1007/s11739-020-02602-x. Epub 2021 Jan 5.
4
Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges.经颈静脉肝内门体分流术(TIPS)相关的分流性肝性脑病:当前治疗方法与临床挑战
J Clin Med. 2020 Nov 23;9(11):3784. doi: 10.3390/jcm9113784.
5
Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.肝硬化患者经颈静脉肝内门体分流术(TIPS)后门静脉高压性脑病的危险因素。
J Dig Dis. 2021 Jan;22(1):31-40. doi: 10.1111/1751-2980.12957. Epub 2020 Nov 26.
6
Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.白蛋白-胆红素评分预测经颈静脉肝内门体分流术患者肝性脑病的效果。
Eur J Gastroenterol Hepatol. 2021 Jun 1;33(6):862-871. doi: 10.1097/MEG.0000000000001801.
7
A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients.用于预测肝硬化患者经颈静脉肝内门体分流术后肝性脑病风险的列线图。
Sci Rep. 2020 Jun 10;10(1):9381. doi: 10.1038/s41598-020-65227-2.
8
Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience.经颈静脉肝内门体分流术(TIPS)后肝性脑病发生和风险的预测因素:15 年经验。
Cardiovasc Intervent Radiol. 2020 Aug;43(8):1156-1164. doi: 10.1007/s00270-020-02512-7. Epub 2020 May 20.
9
A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.一种预测经颈静脉肝内门体分流术患者早期肝性脑病的模型。
Turk J Gastroenterol. 2019 Aug;30(8):702-707. doi: 10.5152/tjg.2019.18485.
10
Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients.糖尿病会增加肝硬化患者经颈静脉肝内门体分流术后肝性脑病的风险。
Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1264-1269. doi: 10.1097/MEG.0000000000001452.